Novartis CEO Vas Narasimhan answers questions about COVID-19.

How much do you know about eyes? Learn more about the fastest muscle in the human body.

Inspired by her mother, Vicky Qi leads drug discovery teams.

Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Targeting inflammation to fight cancer is a new approach with a long history.

By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs

Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.

The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.